Cancer

  • ‘Concerning’ lack of female-only medical trials in UK, say health experts

    British medical experts are raising concerns about the underrepresentation of women in clinical studies, The Guardian reports, with male-only trials outnumbering female-focused research by 67 per cent. Healthcare professionals say they often have to make treatment decisions without enough sex-specific evidence, according to The Guardian’s analysis of comprehensive research data. A joint investigation by the Medicines and Healthcare [...]

  • New approach to treating aggressive breast cancers shows significant improvement in survival

    A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. In a trial where cancers were treated with chemotherapy followed by a targeted cancer drug before surgery, 100 per cent of patients survived the critical three-year period post-surgery. The discovery could become the most effective treatment [...]

  • Three women’s cancer innovators shortlisted for award

    Three women's cancer innovators have been shortlisted for a Femtech World award. The event celebrates some of the best examples of leadership, innovation and impact in key areas that affect women’s health and wellbeing. Through the Women’s Cancer Innovation Award, Femtech World aims to shine a light on the organisations devoted to transforming the future [...]

  • First at-home cervical cancer screening device receives US regulatory approval

    US regulators have approved the first at-home vaginal self-collection device for cervical cancer screening, offering women an alternative to in-clinic exams. The Teal Wand, developed by women's health company Teal Health, allows individuals to collect samples at home without a speculum and send them to a certified laboratory for testing using the same methods as in-clinic [...]

  • AI-human task-sharing could cut mammography screening costs by up to 30 per cent

    The most effective way to harness the power of AI when screening for breast cancer may be through collaboration with human radiologists — not by wholesale replacing them, says new research. The study finds that a “delegation” strategy, where AI helps triage low-risk mammograms and flags higher-risk cases for closer inspection by human radiologists, could [...]

  • International consortium launches US$1m AI grant to tackle ovarian cancer

    An international group of ovarian cancer research charities has launched a new AI-focused grant aimed at accelerating progress in one of the most underfunded and least survivable cancers affecting women worldwide. The Global Ovarian Cancer Research Consortium — a collaboration between organisations in the US, UK, Canada and Australia — has announced a US$1m AI [...]

  • MedTech Companies Paxman and Dignitana Announce Merger

    Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new chapter of working together to advance side effect management for cancer patients around the world. Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB [...]

  • AI could help improve early detection of interval breast cancer

    A new study suggests that AI could help detect interval breast cancer — those that develop between routine screenings — before they become more advanced and harder to treat. This could potentially lead to better screening practices, earlier treatment and improved patient outcomes. The study, led by investigators at the UCLA Health Jonsson Comprehensive Cancer [...]

  • Molecular profiling can safely reduce radiation for women with endometrial cancer, shows study

    A major international study, PORTEC-4a, provides the strongest evidence yet that molecular profiling can safely reduce radiotherapy for women with early stage endometrial cancer while identifying those who would benefit from more intensive treatment. Endometrial cancer is the most common gynaecological cancer in high-developed countries, most often affecting women after menopause. The majority of women [...]

  • North Wales to pilot groundbreaking AI cancer detection tool

    NHS Wales is teaming up with AI tech company, Paige, to launch a new pilot project that will evaluate Paige’s AI-assisted cancer diagnostic application - PanCancer Detect - in what will be the platform's first ever clinical use. Paige's PanCancer Detect is a first of its kind application that detects cancer across multiple organs and [...]